Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Arch Neurol. 2012 Sep;69(9):1132–1140. doi: 10.1001/archneurol.2012.595

Figure 2.

Figure 2

Kaplan-Meier survival curves. A, From time of diagnosis of paraneoplastic neurologic disorder. B, From start time of tacrolimus treatment. The dotted lines indicate 95% confidence intervals; the tick marks, censored patients; and the solid line, the survival curve.